secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2024-02-12T23:59:59+00:00
Accession:  0001683168-24-000866
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences posts investor video by CSO on DNase I oncology preclinical data
--------------------------------------------------------------------------------

- Chief Scientific Officer Curis Lockshin, PhD, discusses preclinical data from DNase I oncology platform.
- Video available at https://www.virtualinvestorco.com/wtm-xbio-8k.
- No financial results, guidance, or material business changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316824000866/0001683168-24-000866-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316824000866/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-000866

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer